Interferon regulatory factor ۵ in Rheumatoid arthritis and systemic lupus erythematosus

  • سال انتشار: 1400
  • محل انتشار: فصلنامه تحقیقات روماتولوژی، دوره: 6، شماره: 1
  • کد COI اختصاصی: JR_RHRE-6-1_001
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 371
دانلود فایل این مقاله

نویسندگان

Hamidreza Ebrahimiyan

Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Zahra Bagheri-Hosseinabadi

Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Department of Clinical Biochemistry, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan,

Mitra Abbasifard

Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Department of Internal Medicine, Ali-Ibn Abi-Talib hospital, School of Medicine, Rafsanjan University

چکیده

 Interferon regulatory factor ۵ (IRF۵) has been described as an important factor in regulating inflammatory response and a key transcription factor in the immune system. In antiviral response, IRF۵ promotes the expression of type ۱ interferon (IFN) and is also important in the differentiation of macrophages towards pro-inflammatory phenotypes, regulating B-cell maturity and antibody production. Some cancer patients treated with IFNα manifest symptoms resembling systemic lupus erythematosus (SLE). An important mechanism in this response is IRF۵ that triggers apoptosis. Herein, we discuss the functional importance of IRF۵ in rheumatoid arthritis (RA) and SLE in a setting of polymorphic mutations at the human Irf۵ locus. This paper describes murine models, the lessons of IRF functionality learned from these models and the consequences of autoimmune diseases. It is hypothesized that modulation of IRF۵ activity may be beneficial in autoimmune diseases therapies. 

کلیدواژه ها

Autoimmune Disease, Interferon regulatory factor ۵ (IRF۵), Rheumatoid arthritis (RA), systemic lupus erythematosus (SLE)

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.